Patent · US Expired

Use of a high purity imidazoline based amphoacetates as surface active agents

US6113809A · kind A · utility

7Cited by
2References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 22, 1996
Grant dateSep 5, 2000
Priority date
Expiry dateOct 22, 2016

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC09K8/594
  • WIPO fieldBasic materials chemistry
  • WIPO sectorChemistry

Abstract

Increased foam quality and resistance to hydrocarbon defoaming for foams used in well boring and stimulation processes as well as secondary and tertiary oil recovery is obtained using imidazoline-based amphoacetates of higher purity, containing essentially negligible amounts of unalkylated amido amines, lower amounts of glycolic acid salts and monochloroacetate salts. The higher purity amphoacetates can be obtained via processes utilizing precise pH control during the reaction of imidazoline, or its open-chain derivatives, with alkylating agents, e.g. sodium monochloroacetate. These higher-purity amphoacetates contain essentially fully alkylated products and lower amounts of glycolic acid derivatives, even though a ratio of monohaloalkylate to substituted imidazoline, or its open-ring derivative, of less than 1.5:1.0 and close to 1.0:1.0 is used.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.